News
-
-
-
PRESS RELEASE
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more -
-
-
PRESS RELEASE
Prospect Ridge Announces Resignation of President and Director
Prospect Ridge Resources Corp. announces Mr. Yan Ducharme's resignation as President and Director, with Len Brownlie assuming the President role. Mike Iverson expresses gratitude for Yan's contribution and highlights exploration plans at Holy Grail and Knauss Creek projects -
-
PRESS RELEASE
Interactive Strength Inc. (Nasdaq:TRNR)'s FORME Named an Exclusive Wellness Partner for Virgin Atlantic's New Clubhouse at LAX
Interactive Strength Inc. announces exclusive partnership with Virgin Atlantic, featuring FORME Studio in Clubhouse at LAX. Partnership enhances wellness experience for travelers -
-
PRESS RELEASE
Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
Nanobiotix announces first data from the completed dose escalation part of a Phase 1 study evaluating NBTXR3 (JNJ-1900) as a 2L+ therapy for patients with locally advanced NSCLC. The study shows favorable safety and injection feasibility, with promising survival data
